Home
SRDX
SRDX News

Latest Surmodics Inc. (SRDX) News on January 19, 2025

After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX)

Zacks

5 days ago

After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX)

SurModics (SRDX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

16 days ago

SurModics (SRDX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Best Momentum Stocks to Buy for January 3rd

Zacks

16 days ago

Best Momentum Stocks to Buy for January 3rd

Why Is SurModics (SRDX) Up 4% Since Last Earnings Report?

Zacks

a month ago

Why Is SurModics (SRDX) Up 4% Since Last Earnings Report?

SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability

TipRanks

2 months ago

SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability

SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why

Zacks

2 months ago

SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why

Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down

Zacks

2 months ago

Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down

SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 months ago

SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

2 months ago

SurModics: Fiscal Q4 Earnings Snapshot

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Business Wire

2 months ago

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System

Business Wire

3 months ago

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System

SRDX Stock Down Despite FDA Clearance for Pounce XL System

Zacks

4 months ago

SRDX Stock Down Despite FDA Clearance for Pounce XL System

MT Newswires

4 months ago

Surmodics Gets FDA Clearance for Pounce XL Thrombectomy System

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

Business Wire

4 months ago

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

4 months ago

SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround

Zacks

4 months ago

Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround

SurModics (SRDX) Loses -6.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

5 months ago

SurModics (SRDX) Loses -6.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Here's What Key Metrics Tell Us About SurModics (SRDX) Q3 Earnings

Zacks

6 months ago

Here's What Key Metrics Tell Us About SurModics (SRDX) Q3 Earnings

SurModics (SRDX) Reports Q3 Loss, Tops Revenue Estimates

Zacks

6 months ago

SurModics (SRDX) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

6 months ago

SurModics: Fiscal Q3 Earnings Snapshot

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Business Wire

6 months ago

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Investors Will Want Surmodics' (NASDAQ:SRDX) Growth In ROCE To Persist

Simply Wall St.

7 months ago

Investors Will Want Surmodics' (NASDAQ:SRDX) Growth In ROCE To Persist

Surmodics (SRDX) Inks Group Purchasing Agreement With Premier

Zacks

7 months ago

Surmodics (SRDX) Inks Group Purchasing Agreement With Premier

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

7 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

7 months ago

Form 8.3 - Darktrace plc

Business Wire

7 months ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

7 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

7 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GlobeNewswire

7 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

7 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

7 months ago

Form 8.3 - International Paper Company

MT Newswires

7 months ago

Surmodics Signs Group Purchasing Deal With Premier

Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

Business Wire

7 months ago

Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

7 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

7 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

7 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

7 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

7 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

7 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

7 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

7 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Why Is Perrigo (PRGO) Down 15.1% Since Last Earnings Report?

Zacks

7 months ago

Why Is Perrigo (PRGO) Down 15.1% Since Last Earnings Report?

Why Is SurModics (SRDX) Up 21.9% Since Last Earnings Report?

Zacks

8 months ago

Why Is SurModics (SRDX) Up 21.9% Since Last Earnings Report?

Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

Zacks

8 months ago

Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

Surmodics agrees to $627M private equity buyout

MedTech Dive

8 months ago

Surmodics agrees to $627M private equity buyout

Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals

Investor's Business Daily

8 months ago

Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals

MT Newswires

8 months ago

Needham Downgrades SurModics to Hold From Buy

MT Newswires

8 months ago

SurModics Agrees to be Acquired by Private Equity Firm GTCR for $627 Million; Shares Rise Pre-Bell

Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

Business Wire

8 months ago

Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price

Simply Wall St.

8 months ago

Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Zacks

8 months ago

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.

9 months ago

Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up

Zacks

9 months ago

Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up

GuruFocus.com

9 months ago

Surmodics Inc (SRDX) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...

MT Newswires

9 months ago

Top Midday Gainers

SurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

9 months ago

SurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

SurModics (SRDX) Q2 Earnings and Revenues Top Estimates

Zacks

9 months ago

SurModics (SRDX) Q2 Earnings and Revenues Top Estimates

Associated Press Finance

9 months ago

SurModics: Fiscal Q2 Earnings Snapshot

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Business Wire

9 months ago

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

Zacks

9 months ago

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

Business Wire

9 months ago

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

9 months ago

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know

Zacks

9 months ago

Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know

Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years

Simply Wall St.

9 months ago

Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years

New Strong Buy Stocks for April 9th

Zacks

9 months ago

New Strong Buy Stocks for April 9th

Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?

Simply Wall St.

10 months ago

Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Zacks

10 months ago

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Are Surmodics, Inc.'s (NASDAQ:SRDX) Mixed Financials Driving The Negative Sentiment?

Simply Wall St.

a year ago

Are Surmodics, Inc.'s (NASDAQ:SRDX) Mixed Financials Driving The Negative Sentiment?

Surmodics to Participate in Upcoming Investor Conferences in March and April

Business Wire

a year ago

Surmodics to Participate in Upcoming Investor Conferences in March and April

Here's What Analysts Are Forecasting For Surmodics, Inc. (NASDAQ:SRDX) After Its First-Quarter Results

Simply Wall St.

a year ago

Here's What Analysts Are Forecasting For Surmodics, Inc. (NASDAQ:SRDX) After Its First-Quarter Results

Here's Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Packet

Simply Wall St.

a year ago

Here's Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Packet

Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View

Zacks

a year ago

Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View

Surmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Surmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call Transcript

Surmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024

GuruFocus.com

a year ago

Surmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024

EverSmith Brands Acquires U.S. Lawns, Expanding Its Landscaping Portfolio

PR Newswire

a year ago

EverSmith Brands Acquires U.S. Lawns, Expanding Its Landscaping Portfolio

SurModics (SRDX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

a year ago

SurModics (SRDX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

SurModics (SRDX) Reports Break-Even Earnings for Q1

Zacks

a year ago

SurModics (SRDX) Reports Break-Even Earnings for Q1

Associated Press Finance

a year ago

SurModics: Fiscal Q1 Earnings Snapshot

2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now

Motley Fool

a year ago

2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now

Haynes International, Inc. to Host First Quarter Fiscal Year 2024 Conference Call

GlobeNewswire

a year ago

Haynes International, Inc. to Host First Quarter Fiscal Year 2024 Conference Call

BrightView Publishes 2024 Corporate Responsibility Report

Business Wire

a year ago

BrightView Publishes 2024 Corporate Responsibility Report

Bank of America, Wells Fargo announce bonuses to rank and file

Banking Dive

a year ago

Bank of America, Wells Fargo announce bonuses to rank and file

Got $3,000? 3 Growth Stocks to Double Up On Right Now

Motley Fool

a year ago

Got $3,000? 3 Growth Stocks to Double Up On Right Now

Opera Limited Sponsored ADR (OPRA) Stock Dips While Market Gains: Key Facts

Zacks

a year ago

Opera Limited Sponsored ADR (OPRA) Stock Dips While Market Gains: Key Facts

CENTERSPACE ANNOUNCES 2023 DIVIDEND ALLOCATIONS

PR Newswire

a year ago

CENTERSPACE ANNOUNCES 2023 DIVIDEND ALLOCATIONS

PRA Group Recognized as River Star Business by Elizabeth River Project

PR Newswire

a year ago

PRA Group Recognized as River Star Business by Elizabeth River Project

Navient (NAVI) to Post Q4 Earnings: What's in the Cards?

Zacks

a year ago

Navient (NAVI) to Post Q4 Earnings: What's in the Cards?

Business First Bancshares, Inc., Announces Financial Results for Fiscal Year 2023 and Q4 2023

GlobeNewswire

a year ago

Business First Bancshares, Inc., Announces Financial Results for Fiscal Year 2023 and Q4 2023

IGI to Release Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Business Wire

a year ago

IGI to Release Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Algoma Steel Provides Update on Incident at Coke-Making Plant

GlobeNewswire

a year ago

Algoma Steel Provides Update on Incident at Coke-Making Plant

16 Most Profitable New Stocks Today

Insider Monkey

a year ago

16 Most Profitable New Stocks Today

Why Accolade (ACCD) Stock Might be a Great Pick

Zacks

a year ago

Why Accolade (ACCD) Stock Might be a Great Pick

AdvanSix Provides Update on Plant Production Rates

Business Wire

a year ago

AdvanSix Provides Update on Plant Production Rates

Liquidia Corporation Announces Updates to Operations Leadership

GlobeNewswire

a year ago

Liquidia Corporation Announces Updates to Operations Leadership

Can Business First (BFST) Keep the Earnings Surprise Streak Alive?

Zacks

a year ago

Can Business First (BFST) Keep the Earnings Surprise Streak Alive?

BrightView Holdings, Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast

Business Wire

a year ago

BrightView Holdings, Inc. Announces First Quarter Fiscal Year 2024 Earnings Release Date, Conference Call and Webcast

Investors in Movado Group (NYSE:MOV) have seen favorable returns of 55% over the past three years

Simply Wall St.

a year ago

Investors in Movado Group (NYSE:MOV) have seen favorable returns of 55% over the past three years

VINCI PARTNERS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2023 RESULTS AND HOST WEBCAST AFTER MARKET CLOSE ON WEDNESDAY, FEBRUARY 07, 2024

PR Newswire

a year ago

VINCI PARTNERS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2023 RESULTS AND HOST WEBCAST AFTER MARKET CLOSE ON WEDNESDAY, FEBRUARY 07, 2024

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

PR Newswire

a year ago

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

Bel Announces a New President of the Power and Protection Segment

GlobeNewswire

a year ago

Bel Announces a New President of the Power and Protection Segment

Share on Social Networks: